Friday, June 14, 2024

Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft (Marina Temkin/TechCrunch)

Marina Temkin / TechCrunch:
Boulder, Colorado-based Enveda, which combines AI with ancient remedies for drug discovery, raised a $55M Series B extension from investors including Microsoft  —  For centuries, people chewed willow tree bark to relieve pain, but scientists at chemical firm Bayer didn't isolate its active ingredient until the 1800s



No comments:

Post a Comment

A look at the troubled rollout of the EU's automated biometric entry/exit border system, as airport operators warn of severe delays ahead of the summer holidays (Financial Times)

Financial Times : A look at the troubled rollout of the EU's automated biometric entry/exit border system, as airport operators warn o...